The use of mifepristone for breast and ovarian cancer, while suppressing the PIBF protein, may also negate the role that the nPR plays in inhibiting possibly some other protein, e.g., hypothetically, PGRMC-1, that promotes tumor proliferation. This evidence concerns the gene PIBF1 and ovarian carcinoma.